2JH-17330-47259
3 vaccinations
4 coded responses
31 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
KZ3-30701-66317
Child or adolescent in my care · Male · 2021-11-07
3FX-29450-61191
Child or adolescent in my care · Female · 2021-11-07
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Fever · Muscle or body achesFree text: Swollen lymph nodes under jawMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Muscle or body achesAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body achesAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
-
2021-04-25
Survey response — day 14, dose 2MedDRA: Cough, Dyspnoea, Fatigue, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: PoorFree text: Shortness of breath, coughing, stuffy/runny nose, some general fatigue. Negative for Covid (got tested on 4/23).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-02
-
2021-05-09
Survey response — day 28, dose 2MedDRA: Asthma, Dyspnoea, Hypersensitivity, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Trouble breathing. Likely allergy, asthma relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-16
- 2021-05-23
- 2021-07-11
- 2021-10-10
-
2021-11-04
Dose 3 — Moderna
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body achesAdult check-in
- 2021-11-09
-
2021-11-11
Health check-in — day 7, dose 3Feeling: Poor · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-11-21
- 2021-11-25
- 2022-02-03
- 2022-05-05
-
2022-11-06
Survey response — 12 months, dose 3MedDRA: Asthma, COVID-19, Dyspnoea, Fatigue, Lung disorder, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Not sure if last contact but had COVID in May 2022. Symptoms were sore throat, shortness of breath, & general fatigue. I experienced lung issues (have asthma) needing multiple times per day albuterol treatments for ~6 weeks after. Took PaxlovidMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes under jaw
Release 7 — day 14, dose 2
Symptoms: Shortness of breath, coughing, stuffy/runny nose, some general fatigue. Negative for Covid (got tested on 4/23).
Release 8 — day 28, dose 2
Symptoms: Trouble breathing. Likely allergy, asthma related
Release 12 — 12 months, dose 3
Symptoms: Not sure if last contact but had COVID in May 2022. Symptoms were sore throat, shortness of breath, & general fatigue. I experienced lung issues (have asthma) needing multiple times per day albuterol treatments for ~6 weeks after. Took Paxlovid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release